Newronika develops an adaptive deep brain stimulation system to enhance precision therapy for Parkinson’s disease patients using real-time patient data.

Freya Biosciences is a biotech company advancing women's reproductive health through the development of vaginal microbial immunotherapeutics for infertility associated with dysbiotic vaginal microbiota in patients undergoing assisted reproductive technology.

Hoba Therapeutics is a biotech firm specializing in developing novel treatments for painful Chemotherapy-Induced Peripheral Neuropathy and sensorineural hearing loss, currently advancing their lead drug candidate, HB-086, towards Phase 1 clinical trials.

Nouscom is a clinical-stage immuno-oncology company specializing in off-the-shelf and personalized cancer immunotherapies using a proprietary viral vector platform.